Biology of PPAR gamma in cancer: a critical review on existing lacunae
about
Signaling Interplay between Bone Marrow Adipose Tissue and Multiple Myeloma cellsOmega-3 Fatty Acids and PPARgamma in CancerRetinoids in the treatment of glioma: a new perspective.De-novo identification of PPARgamma/RXR binding sites and direct targets during adipogenesis.Tumor grade related expression of neuroglobin is negatively regulated by PPARγ and confers antioxidant activity in glioma progressionPPARγ activation by troglitazone enhances human lung cancer cells to TRAIL-induced apoptosis via autophagy fluxThe role of the PAX8/PPARgamma fusion oncogene in the pathogenesis of follicular thyroid cancerAlterations in lipid mediated signaling and Wnt/ β -catenin signaling in DMH induced colon cancer on supplementation of fish oil.Nrf2-regulated PPAR{gamma} expression is critical to protection against acute lung injury in miceHonokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase-1 and consequent inhibition of peroxisome proliferator-activated receptor-gamma and COX-2-dependent signalsAnticancer actions of PPARγ ligands: Current state and future perspectives in human lung cancerBody mass index and obesity- and diabetes-associated genotypes and risk for pancreatic cancer.Mechanisms of obesity-induced gastrointestinal neoplasiaThe PPARγ agonist, rosiglitazone, attenuates airway inflammation and remodeling via heme oxygenase-1 in murine model of asthmaOxidized glycerophosphocholines as biologically active mediators for ultraviolet radiation-mediated effects.Peroxisome proliferator-activated receptor-γ is downregulated in ulcerative colitis and is involved in experimental colitis-associated neoplasiaThe role of peroxisome proliferator-activated receptors in colorectal cancer.Mechanisms Mediating the Effects of γ-Tocotrienol When Used in Combination with PPARγ Agonists or Antagonists on MCF-7 and MDA-MB-231 Breast Cancer CellsThe Role of PPAR-gamma and Its Interaction with COX-2 in Pancreatic Cancer.PPARgamma and Proline Oxidase in Cancer.Activated PPARgamma Targets Surface and Intracellular Signals That Inhibit the Proliferation of Lung Carcinoma Cells.Thiazolidinedione therapy is not associated with increased colonic neoplasia risk in patients with diabetes mellitus.α-linolenic acid inhibits human renal cell carcinoma cell proliferation through PPAR-γ activation and COX-2 inhibition.Role of peroxisome proliferator-activated receptor gamma and its ligands in the treatment of hematological malignanciesNO-Donating NSAIDs, PPARdelta, and Cancer: Does PPARdelta Contribute to Colon Carcinogenesis?Prognostic and therapeutic potential of nuclear receptors in head and neck squamous cell carcinomas.Proteomics revisits the cancer metabolome.Blocking the peroxisome proliferator-activated receptor (PPAR): an overview.Lentiviral delivery of PPARγ shRNA alters the balance of osteogenesis and adipogenesis, improving bone microarchitecture.Key genes and pathways predicted in papillary thyroid carcinoma based on bioinformatics analysis.Peroxisome Proliferator-Activated Receptor Ligands and Their Role in Chronic Myeloid Leukemia: Therapeutic Strategies.Combinational effect of PPARγ agonist and RXR agonist on the growth of SGC7901 gastric carcinoma cells in vitro.Thermodynamics in cancers: opposing interactions between PPAR gamma and the canonical WNT/beta-catenin pathway.Nutrition Modulation of Cardiotoxicity and Anticancer Efficacy Related to Doxorubicin Chemotherapy by Glutamine and ω-3 Polyunsaturated Fatty Acids.Mesozeaxanthin protects the liver and reduces cardio-metabolic risk factors in an insulin resistant rodent model.Peroxisome proliferator-activated receptor gamma ligand-mediated apoptosis of hepatocellular carcinoma cells depends upon modulation of PI3Kinase pathway independent of Akt.3T3-L1 adipocyte apoptosis induced by thiazolidinediones is peroxisome proliferator-activated receptor-gamma-dependent and mediated by the caspase-3-dependent apoptotic pathway.Head and neck cancers, the neglected malignancies: present and future treatment strategies.Identifying and analyzing different cancer subtypes using RNA-seq data of blood platelets.PPARgamma is involved in mesalazine-mediated induction of apoptosis and inhibition of cell growth in colon cancer cells.
P2860
Q26744596-AFDEBFBE-45CF-47AE-9BAF-9A8E037A30BEQ28292907-7057438D-5187-4432-8FB0-E11F7B2F5A9EQ30464615-86145455-BCF7-414F-A10E-09B82B881CA3Q33419872-3DE2C47E-6D44-497D-B0A9-68F3A3CA4B7AQ33561578-DFD7D7E7-EE68-460D-A1EE-498E49F6FF62Q33688828-C24C7FB0-4F64-43FF-B04B-35DA90681AC0Q33770842-D9AC0E2C-2DE8-4FBE-B880-FDCBF2F14E5AQ33791932-788E5918-EEAE-4332-BECE-27CC482821A8Q34032853-E8FA8B74-A43B-499A-A107-C7DCE805AB70Q34219578-243B4ABF-464D-43B8-AB33-B6EF26714EBEQ34878637-7EC81E27-E847-4CB8-BFAF-B578EC38647CQ34949479-478CC37E-EA24-4305-A851-DBD4323997E0Q35062195-BBC3A983-4794-46B4-87C5-46BC5C737FD0Q35080151-EBFEFCE0-5B0C-46E3-986E-B0B92474B046Q35932617-65374F17-D780-4727-8A4B-F03EDAF2B70BQ35943219-F09A4FC5-36B9-4D6C-9B13-E92A1572C69FQ36248494-F656FFC1-41DF-4003-A781-C0C445F76DFFQ36602967-A4FE03E6-DFB5-4C87-ABD7-5BC26729327EQ36742740-C7548974-3153-477D-A2D6-348B2EF572F9Q36798663-601185EA-441E-4CCB-8965-0E0F3AA1DC47Q36836697-2D31DCBE-AD43-44A8-ABA6-D4DCE3D6D1D2Q37066317-309205AD-5EB7-47EB-99CE-2BDFA9B4A8A0Q37093109-A1ABDCD9-66CA-423F-B21E-AC12CC9ADCEBQ37182794-8B0A3FC4-A1C7-4D24-B93E-FEF16B2A4631Q37182798-554B2839-1741-4795-A21B-1E2119E6E463Q37606299-B9B04F40-B879-447E-BA41-9FBF05192000Q37912205-3CBA69FF-4241-4853-82FC-C68F7F5FA180Q38128537-15ED6225-5D2F-4B38-B0E6-DCFFCAB68A71Q38307418-5F46274E-0C03-47FB-BFC3-8DC711C3ECA2Q38441699-E9F25557-375D-42DF-9082-E13B6AA29149Q38721726-0D5DC1F9-ACED-4E01-A5FE-F76E8F1CC8C9Q39162746-5CD5332A-0A9C-41F1-B6BC-BEEBB4C94B31Q39239818-2D30A672-5D8F-4502-AA67-7DAD995F8C49Q41048612-62ABDB17-47A5-453C-935D-2E1DE7118CDAQ41167222-4F6733BB-01FE-47E3-B1F8-E1F3D2EFB139Q41468565-9E5C055B-C312-46CC-A595-6E68FA25EA89Q42830687-8C5A01FB-7DB4-4F76-89E7-319B674636D2Q44655644-3307AF53-3538-4AF1-9629-9C6616579D92Q45943794-3F751E11-FF97-44C2-B121-636083E357FEQ46547392-64E900F3-6C16-4CD8-8267-474266E1B260
P2860
Biology of PPAR gamma in cancer: a critical review on existing lacunae
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Biology of PPAR gamma in cancer: a critical review on existing lacunae
@ast
Biology of PPAR gamma in cancer: a critical review on existing lacunae
@en
Biology of PPAR gamma in cancer: a critical review on existing lacunae
@nl
type
label
Biology of PPAR gamma in cancer: a critical review on existing lacunae
@ast
Biology of PPAR gamma in cancer: a critical review on existing lacunae
@en
Biology of PPAR gamma in cancer: a critical review on existing lacunae
@nl
prefLabel
Biology of PPAR gamma in cancer: a critical review on existing lacunae
@ast
Biology of PPAR gamma in cancer: a critical review on existing lacunae
@en
Biology of PPAR gamma in cancer: a critical review on existing lacunae
@nl
P2093
P3181
P1476
Biology of PPAR gamma in cancer: a critical review on existing lacunae
@en
P2093
Anand Krishnan
M Radhakrishna Pillai
S Asha Nair
P304
P3181
P356
10.2174/156652407781695765
P407
P577
2007-09-01T00:00:00Z